Sobi to buy US rights to AstraZeneca’s Synagis drug for $1.5bn
Wednesday, November 14, 2018 Swedish biopharmaceutical firm Swedish Orphan Biovitrum (Sobi) has signed agreements to acquire the rights to AstraZeneca’s
Read More
Wednesday, November 14, 2018 Swedish biopharmaceutical firm Swedish Orphan Biovitrum (Sobi) has signed agreements to acquire the rights to AstraZeneca’s
Read MoreTuesday, November 13, 2018 A survey by the World Health Organization (WHO) has revealed huge variations in the use of
Read MoreTuesday, November 06, 2018 DrugName : adalimumab AbbVie announced patent license agreements with Momenta over its proposed biosimilar adalimumab product. Under
Read MoreTuesday, November 06, 2018 Suven Life Sciences Ltd., announces that the grant of one (1) product patent from Israel (255994)
Read MoreMonday, November 05, 2018 ResApp Health Limited, a leading digital health company developing smartphone applications for the diagnosis and management
Read More